Jan. 17 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 28 November 2022Found: MedDRA 25.1 Reaction Name TotalFatal Neoplasms Bone neoplasms malignant (excl sarcomas) Bone cancer
Jan. 17 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 28 November 2022Found: Version: MedDRA 25.1 Reaction Name TotalFatal Neoplasms Bladder neoplasms malignant Bladder cancer
Jan. 17 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 28 November 2022Found: WARNINGS AND PRECAUTIONS FOR USE¿ SECTION 4.8 WORKSH ARING UNDESIRABLE EFFECTS¿ IN RELATION WITH OVARIAN
Jan. 17 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 22 August 2022Found: D E N T I A L I N F O R M A T I O N7/58EPIC European Prospective Investigation into Nutrition and Cancer
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will make it her policy to develop a specific strategy on (a) research, (b) early diagnosis and (c) treatment for less survivable cancers.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
We currently do not have such plans. Making improvements across different cancer types is critical to helping achieve the NHS Long Term Plan ambition of diagnosing 75% of patients at an early stage by 2028 and reducing inequalities in cancer survival. Through NHS England, the Government is taking steps to improve outcomes for cancer patients, including those with less survivable cancers.
The planned Major Conditions Strategy will look at the early diagnosis and treatment of cancer. The Strategy will look at a wide range of interventions and enablers to improve outcomes and experience for a range of cancer patients.
NHS England has commissioned new cancer clinical audits covering five cancer types, some of which are less survivable: pancreatic cancer, ovarian cancer, non-Hodgkin lymphoma, kidney cancer and primary and metastatic breast cancer. All five audits will cover care delivered in England and Wales and will see an investment of approximately £5.4 million for an initial period of three years.
The NHS ‘Help Us, Help You’ (HUHY) cancer campaigns increase awareness of cancer symptoms and encourage people to get checked. Some campaigns focus on specific symptoms linked to less survivable cancers, such as the HUHY abdominal and urological symptoms campaign, while others focus on fear as a barrier to help-seeking, which is relevant to all cancer types.
Asked by: Baillie, Jackie (Scottish Labour - Dumbarton)
Question
To ask the Scottish Government what information it has on how many women in the West Scotland region have had ovarian cancer surgery privately in each of the last five years.
Answered by Minto, Jenni - Minister for Public Health and Women's Health
This information is not held centrally by the Scottish Government.
Jan. 12 2024
Source Page: Official statistics: forthcoming publicationsFound: . 0131 314 1707 e-mail: ewout.jaspers@phs.scot WeeklyNot applicableOfficial StatisticsSystemic Anti-Cancer
Oral Evidence Jan. 09 2024
Inquiry: Future cancerFound: We will focus on pancreatic cancer, brain cancer and respiratory cancers, including lung cancer and
Jan. 09 2024
Source Page: Letter dated 27/12/2023 from Lord Markham to Baroness Hayter and other peers regarding the General Medical Council's internal guidance for pregnant and menopausal women. 2p.Found: In July 2023, NHS.UK published updated content on cervical cancer, ovulation pain, period pain, irregular
Asked by: Baillie, Jackie (Scottish Labour - Dumbarton)
Question
To ask the Scottish Government what its response is to reports that women in the west of Scotland have experienced considerable delays in accessing ovarian cancer surgery.
Answered by Minto, Jenni - Minister for Public Health and Women's Health
The Scottish Government is aware of instances of women who have faced significant delays in accessing ovarian cancer surgery in the west of Scotland. Due to the multidisciplinary nature of the surgery for ovarian cancer, scheduling can be challenging for health boards. NHS Greater Glasgow and Clyde (GGC) has advised that action is being taken to simplify scheduling of these cases and thus reduce delays.
Actions taken have included increasing dedicated theatre capacity and improving joint working across surgical teams. The health board is working to increase dedicated time for surgeons from the colorectal, urology, plastic and hepato-pancreatic biliary teams to operate jointly with gynaecology oncology. The surgical team is now bigger, with further training in hand. There has been an increase in weekly operating lists and planning continues to improve around increased access to other surgical specialties.
The Centre for Sustainable Delivery is leading improvement work and pathway redesign via their clinically led specialty delivery group (SDG) for gynaecology. This includes in-depth peer review meetings involving all Boards in NHS Scotland to ensure gynaecology patients are on the right pathway at the right time, supporting improvements in waiting times and patient outcomes.
The Scottish Cancer Network will be establishing a new National Ovarian Cancer Clinical Network, which will work to ensure equity of access to treatment for all women with ovarian cancer in Scotland.